| Other Financial Statement Information |
3. OTHER FINANCIAL STATEMENT INFORMATION Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30,
2026 |
|
|
December 31,
2025 |
|
Prepaid drug manufacturing costs |
|
$ |
9,978 |
|
|
$ |
1,637 |
|
Interest income receivable |
|
|
3,928 |
|
|
|
3,285 |
|
Prepaid clinical trial costs |
|
|
2,930 |
|
|
|
3,435 |
|
Prepaid commercial planning costs |
|
|
2,562 |
|
|
|
359 |
|
Prepaid software costs |
|
|
2,448 |
|
|
|
1,669 |
|
Prepaid medical affairs costs |
|
|
2,277 |
|
|
|
486 |
|
Other |
|
|
4,209 |
|
|
|
3,423 |
|
Total prepaid expenses and other current assets |
|
$ |
28,332 |
|
|
$ |
14,294 |
|
Other Noncurrent Assets Other noncurrent assets consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30,
2026 |
|
|
December 31,
2025 |
|
Operating lease right-of-use assets |
|
$ |
1,687 |
|
|
$ |
1,923 |
|
Deferred debt issuance costs |
|
|
1,578 |
|
|
|
2,473 |
|
Property and equipment, net |
|
|
813 |
|
|
|
1,374 |
|
Internal-use software |
|
|
800 |
|
|
|
— |
|
Other |
|
|
613 |
|
|
|
80 |
|
Total other noncurrent assets |
|
$ |
5,491 |
|
|
$ |
5,850 |
|
Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30,
2026 |
|
|
December 31,
2025 |
|
Accrued payroll |
|
$ |
12,151 |
|
|
$ |
18,700 |
|
Accrued drug manufacturing costs |
|
|
10,283 |
|
|
|
8,427 |
|
Accrued commercial planning expenses |
|
|
4,452 |
|
|
|
1,181 |
|
Accrued clinical trial costs |
|
|
4,131 |
|
|
|
1,333 |
|
Other |
|
|
2,731 |
|
|
|
1,916 |
|
Total accrued expenses and other current liabilities |
|
$ |
33,748 |
|
|
$ |
31,557 |
|
|